Literature DB >> 20186410

Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis.

Marco Girhard1, Tobias Klaus, Yogan Khatri, Rita Bernhardt, Vlada B Urlacher.   

Abstract

The oxidizing activity of CYP109B1 from Bacillus subtilis was reconstituted in vitro with various artificial redox proteins including putidaredoxin reductase and putidaredoxin from Pseudomonas putida, truncated bovine adrenodoxin reductase and adrenodoxin, flavodoxin reductase and flavodoxin from Escherichia coli, and two flavodoxins from B. subtilis (YkuN and YkuP). Binding and oxidation of a broad range of chemically different substrates (fatty acids, n-alkanes, primary n-alcohols, terpenoids like (+)-valencene, alpha- and beta-ionone, and the steroid testosterone) were investigated. CYP109B1was found to oxidize saturated fatty acids (conversion up to 99%) and their methyl and ethyl esters (conversion up to 80%) at subterminal positions with a preference for the carbon atoms C11 and C12 counted from the carboxyl group. For the hydroxylation of primary n-alcohols, the omega(-2) position was preferred. n-Alkanes were not accepted as substrates by CYP109B1. Regioselective hydroxylation of terpenoids alpha-ionone (approximately 70% conversion) and beta-ionone (approximately 91% conversion) yielded the allylic alcohols 3-hydroxy-alpha-ionone and 4-hydroxy-beta-ionone, respectively. Furthermore, indole was demonstrated to inhibit fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186410     DOI: 10.1007/s00253-010-2472-z

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  13 in total

1.  Products of gut-microbial tryptophan metabolism inhibit the steroid hormone-synthesizing cytochrome P450 11A1.

Authors:  A Mosa; A Gerber; J Neunzig; Rita Bernhardt
Journal:  Endocrine       Date:  2016-02-02       Impact factor: 3.633

2.  Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.

Authors:  Katharina Roellecke; Vera D Jäger; Veselin H Gyurov; John P Kowalski; Stephanie Mielke; Allan E Rettie; Helmut Hanenberg; Constanze Wiek; Marco Girhard
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

3.  Biocatalytic synthesis of flavones and hydroxyl-small molecules by recombinant Escherichia coli cells expressing the cyanobacterial CYP110E1 gene.

Authors:  Takuya Makino; Toshihiko Otomatsu; Kazutoshi Shindo; Emi Kitamura; Gerhard Sandmann; Hisashi Harada; Norihiko Misawa
Journal:  Microb Cell Fact       Date:  2012-07-18       Impact factor: 5.328

4.  A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol.

Authors:  Simone Brixius-Anderko; Lina Schiffer; Frank Hannemann; Bernd Janocha; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2015-09-15       Impact factor: 5.328

5.  Design and improvement of artificial redox modules by molecular fusion of flavodoxin and flavodoxin reductase from Escherichia coli.

Authors:  Patrick J Bakkes; Stefan Biemann; Ansgar Bokel; Marc Eickholt; Marco Girhard; Vlada B Urlacher
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

6.  Steroid conversion with CYP106A2 - production of pharmaceutically interesting DHEA metabolites.

Authors:  Daniela Schmitz; Josef Zapp; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2014-06-05       Impact factor: 5.328

7.  Identification, characterization and molecular adaptation of class I redox systems for the production of hydroxylated diterpenoids.

Authors:  Christian Görner; Patrick Schrepfer; Veronika Redai; Frank Wallrapp; Bernhard Loll; Wolfgang Eisenreich; Martin Haslbeck; Thomas Brück
Journal:  Microb Cell Fact       Date:  2016-05-23       Impact factor: 5.328

8.  Fusion to Hydrophobin HFBI Improves the Catalytic Performance of a Cytochrome P450 System.

Authors:  Sebastian Schulz; Dominik Schumacher; Daniel Raszkowski; Marco Girhard; Vlada B Urlacher
Journal:  Front Bioeng Biotechnol       Date:  2016-07-04

9.  Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium.

Authors:  Ilona K Jóźwik; Flora M Kiss; Łukasz Gricman; Ammar Abdulmughni; Elisa Brill; Josef Zapp; Juergen Pleiss; Rita Bernhardt; Andy-Mark W H Thunnissen
Journal:  FEBS J       Date:  2016-10-17       Impact factor: 5.542

10.  Engineering of versatile redox partner fusions that support monooxygenase activity of functionally diverse cytochrome P450s.

Authors:  Patrick J Bakkes; Jan L Riehm; Tanja Sagadin; Ansgar Rühlmann; Peter Schubert; Stefan Biemann; Marco Girhard; Michael C Hutter; Rita Bernhardt; Vlada B Urlacher
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.